Century Therapeutics, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-34.6M | $-21.6M | $-19.2M | $-34.4M | $-32.5M | $76.6M | $-36.1M | $-31.2M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $26.0K | $3.0M | $3.6M | $3.1M | $3.2M | $3.2M | $3.3M | $3.3M |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $2.0M | $1.4M | $1.3M | $892.0K | $2.2M | $2.4M | $2.7M | $3.3M |
| Net Cash from Operating Activities | $-19.8M | $-25.3M | $-16.1M | $-25.6M | $-27.6M | $-34.6M | $-24.2M | $-28.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $694.0K | $584.0K | $-139.0K | $195.0K | $317.0K | $475.0K | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $17.8M | $-112.6M | $22.4M | $24.7M | $32.5M | $27.9M | $30.6M | $39.2M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $311.0K | $126.6M | $53.0K | $0 | $0 | $120.0K | $-602.0K | $273.0K |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | $-20.5M | $-25.8M | $-15.9M | $-25.8M | $-27.9M | $-35.1M | — | — |